Recursion Pharmaceuticals (RXRX) Stock Price & Financial Analysis
Recursion Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Recursion Pharmaceuticals
What is the current stock price for RXRX?
As of the latest trading session, RXRX stock trades at $3.11. The 52-week range is $2.80–$7.18, with a day range of $2.93–$3.13.
What is the P/E ratio for RXRX?
The P/E ratio (Price-to-Earnings) for RXRX is shown in the Key Statistics section. This valuation metric helps compare Recursion Pharmaceuticals, Inc. to industry peers.
Does RXRX pay dividends?
Recursion Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RXRX?
Based on 2 analysts, the consensus for RXRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of RXRX?
Recursion Pharmaceuticals's market capitalization is $1.64B, classifying it as a small-cap company. Recursion Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.